Document is current
Any future updates will be listed below
-
Authors
Zhang, Peng
Zheng, Hongyu
Lin, Zhao
Zhang, Minjuan
Yang, Linhai
Deng, Zhibo
Song, Chao
Dai, Hanhao
Su, Yibin
Zhang, Rongsheng
Yu, Guoyu
Luo, Jun
Xu, Jie
Luo, Fenqi
-
Funding
Funding for this research was provided by:
Fujian Provincial Natural Science Foundation Projects (2022J011016)
Fujian Provincial Natural Science Foundation Projects (2025J01120249)
- License Information
-
More Information
Article History
Received: 1 October 2025
Accepted: 23 February 2026
First Online: 11 March 2026
Declarations
:
: For animal experiments, the study entitled “Molecular mechanism of downregulating TSPO to promote osteogenic differentiation of bone marrow mesenchymal stem cells and its therapeutic effect on osteoporosis” was approved by the Animal Ethics Committee of Fujian Provincial Hospital (IACUC-FPH-SL-20250221[0752]) on February 21, 2025, and performed according to the guidelines for ARRIVE guidelines 2.0. For human experiments, he study entitled “Molecular mechanism of downregulating TSPO to promote osteogenic differentiation of bone marrow mesenchymal stem cells and its therapeutic effect on osteoporosis” was approved by the Ethics Committee of Fujian Provincial Hospital (K2025-02-169) on February 21, 2025 and performed in line with the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
